PHARMACOKINETICS OF RILMENIDINE IN HEALTHY-SUBJECTS

被引：13

作者：

GENISSEL, P

BROMET, N

FOURTILLAN, JB

MIGNOT, A

ALBIN, H

机构：

[1] CEPHAC,POITIERS,FRANCE

[2] UNIV BORDEAUX 2,PHARMACOL LAB,F-33076 BORDEAUX,FRANCE

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1988年 / 61卷 / 07期

关键词：

D O I：

10.1016/0002-9149(88)90465-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：D47 / D53

页数：7

共 14 条

[1] GAS-CHROMATOGRAPHIC NEGATIVE-ION MASS-SPECTROMETRIC ASSAY OF 2-DICYCLOPROPYLMETHYLAMINO-2-OXAZOLINE (S-3341), A NEW ANTIHYPERTENSIVE DRUG [J].

EHRHARDT, JD .

BIOMEDICAL MASS SPECTROMETRY, 1985, 12 (10) :593-595

[2]

FILLASTRE JP, 1987, 3RD EUR M HYP MIL

[3]

GIBALDI M, 1984, BIOPHARMACEUTICS CLI

[4]

GUICHENEY P, 1981, J PHARMACOL-PARIS, V12, P255

[5]

LAUBIE M, 1985, J PHARMACOL-PARIS, V16, P259

[6] INFLUENCE OF FOOD ON BIOAVAILABILITY OF DRUGS [J].

MELANDER, A .

CLINICAL PHARMACOKINETICS, 1978, 3 (05) :337-351

[7]

MURRAY S, 1985, BIOMED MASS SPECTROM, V12, P230, DOI 10.1002/bms.1200120509

[8] NON-COMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION FOR ANY MODE OF ADMINISTRATION [J].

PERRIER, D ;

MAYERSOHN, M .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (03) :372-373

[9]

Rowland M, 1980, CLIN PHARMACOKINETIC

[10]

SPRIET A, 1978, EUR J DRUG METAB PH, V2, P129

← 1 2 →